HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael W Otto Selected Research

Panic Disorder (Panic Attack)

1/2020Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
1/2016RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
7/2015The role of distress intolerance for panic and nicotine withdrawal symptoms during a biological challenge.
12/2014The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function.
5/2012Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
11/2011Memory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use.
3/2011Predictors of relapse in the second follow-up year post cognitive-behavior therapy for panic disorder.
8/2010Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.
2/2010Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
11/2009Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael W Otto Research Topics

Disease

24Anxiety Disorders (Anxiety Disorder)
11/2021 - 07/2002
23Panic Disorder (Panic Attack)
01/2020 - 05/2002
14Bipolar Disorder (Manic Depressive Psychosis)
10/2016 - 07/2002
13Substance-Related Disorders (Drug Abuse)
01/2018 - 01/2004
8Social Phobia
01/2020 - 03/2006
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2017 - 11/2003
4Schizophrenia (Dementia Praecox)
06/2013 - 01/2004
3Mental Disorders (Mental Disorder)
01/2021 - 03/2011
2Opioid-Related Disorders (Opiate Addiction)
01/2021 - 01/2020
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
09/2020 - 07/2015
2Sleep Initiation and Maintenance Disorders (Insomnia)
06/2013 - 09/2004
2Phobic Disorders (Phobia)
06/2013 - 03/2006
2Mood Disorders (Mood Disorder)
04/2013 - 03/2012
2Agoraphobia
11/2011 - 07/2002
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
08/2010 - 10/2004
2Major Depressive Disorder (Major Depressive Disorders)
10/2005 - 06/2005
1COVID-19
10/2022
1Shock
08/2022
1Inflammation (Inflammations)
12/2018
1Acidosis
12/2014
1Asphyxia (Suffocation)
12/2014
1Hypersensitivity (Allergy)
12/2014
1Personality Disorders (Personality Disorder)
06/2013
1Feeding and Eating Disorders (Eating Disorder)
06/2013
1Pain (Aches)
03/2012
1Autism Spectrum Disorder
08/2011
1Alcoholism (Alcohol Abuse)
04/2010
1Dizziness (Lightheadedness)
01/2009
1Mania (Manias)
04/2007
1Tuberculosis (Tuberculoses)
11/2006
1Wounds and Injuries (Trauma)
11/2005
1Cognitive Dysfunction
01/2005

Drug/Important Bio-Agent (IBA)

22Cycloserine (Seromycin)FDA Link
01/2020 - 03/2006
9Pharmaceutical PreparationsIBA
01/2021 - 01/2004
7BenzodiazepinesIBA
11/2011 - 06/2003
4Paroxetine (Paxil)FDA LinkGeneric
03/2008 - 09/2003
3Illicit Drugs (Recreational Drugs)IBA
01/2020 - 03/2012
3Methadone (Dolophine)FDA LinkGeneric
01/2020 - 08/2010
3Biological ProductsIBA
07/2015 - 07/2002
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2013 - 03/2006
3Anti-Anxiety Agents (Anxiolytics)IBA
04/2013 - 10/2004
2Cocaine (Cocaine HCl)IBA
08/2022 - 11/2005
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 12/2018
2NicotineFDA Link
09/2020 - 07/2015
2Antidepressive Agents (Antidepressants)IBA
01/2017 - 04/2007
2Carbon DioxideIBA
07/2015 - 12/2014
2Nootropic Agents (Nootropics)IBA
07/2015 - 08/2011
2Heroin (Diamorphine)IBA
08/2010 - 07/2008
2Fluoxetine (Prozac)FDA LinkGeneric
10/2005 - 06/2005
2Clonazepam (Rivotril)FDA LinkGeneric
09/2004 - 09/2003
2Sertraline (Zoloft)FDA LinkGeneric
11/2003 - 07/2002
1VaccinesIBA
10/2022
1COVID-19 VaccinesIBA
10/2022
1SmokeIBA
11/2021
1Sulfhydryl Compounds (Thiols)IBA
12/2018
13-nitrotyrosineIBA
12/2018
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
12/2018
1Proteins (Proteins, Gene)FDA Link
12/2018
1Thiobarbituric Acid Reactive SubstancesIBA
12/2018
1Acid Sensing Ion ChannelsIBA
12/2014
1Yohimbine (Yocon)IBA
06/2014
1D 53IBA
06/2014
1Therapeutic UsesIBA
04/2013
1Glutamate Receptors (Glutamate Receptor)IBA
05/2012
1Glycine Plasma Membrane Transport ProteinsIBA
05/2012
1N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA
05/2012
1N-Methylaspartate (NMDA)IBA
05/2012
1GlucocorticoidsIBA
06/2010
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
04/2010
1Clozapine (Clozaril)FDA LinkGeneric
12/2008
1Antipsychotic Agents (Antipsychotics)IBA
12/2008
1Crack CocaineIBA
07/2008
1Imipramine (Janimine)FDA LinkGeneric
07/2007
1Anti-Bacterial Agents (Antibiotics)IBA
11/2006
1Amphetamine (Amfetamine)FDA LinkGeneric
11/2005
1Hypericum extract LI 160IBA
10/2005
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
09/2003
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
06/2003
1LithiumIBA
07/2002

Therapy/Procedure

25Drug Therapy (Chemotherapy)
10/2016 - 05/2002
16Therapeutics
02/2014 - 07/2002
1Cognitive Training
03/2011
1Treatment Delay
01/2009
1Aftercare (After-Treatment)
06/2003
1Secondary Prevention
06/2003